These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 34961399)
1. Discriminating between Waldenström macroglobulinemia and marginal zone lymphoma using logistic LASSO regression. Amaador K; Vos JMI; Pals ST; Kraan W; Dobber JA; Minnema MC; Koene HR; de Bruin PC; Zwinderman AH; Kersten MJ Leuk Lymphoma; 2022 May; 63(5):1070-1079. PubMed ID: 34961399 [TBL] [Abstract][Full Text] [Related]
2. Lymphoplasmacytic lymphoma and marginal zone lymphoma in the bone marrow: paratrabecular involvement as an important distinguishing feature. Bassarova A; Trøen G; Spetalen S; Micci F; Tierens A; Delabie J Am J Clin Pathol; 2015 Jun; 143(6):797-806. PubMed ID: 25972321 [TBL] [Abstract][Full Text] [Related]
3. An unusual case of cutaneous Waldenström macroglobulinemia with the MYD88 L265P mutation. Minzenmayer AN; Miranda RN; Powell PR; Parekh PK J Cutan Pathol; 2020 Sep; 47(9):850-853. PubMed ID: 32335928 [TBL] [Abstract][Full Text] [Related]
4. Lymphoplasmacytic lymphoma and Waldenström macroglobulinaemia: clinicopathological features and differential diagnosis. Wang W; Lin P Pathology; 2020 Jan; 52(1):6-14. PubMed ID: 31767130 [TBL] [Abstract][Full Text] [Related]
5. MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma. Martinez-Lopez A; Curiel-Olmo S; Mollejo M; Cereceda L; Martinez N; Montes-Moreno S; Almaraz C; Revert JB; Piris MA Am J Surg Pathol; 2015 May; 39(5):644-51. PubMed ID: 25723115 [TBL] [Abstract][Full Text] [Related]
7. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia. Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic features of Waldenstrom's macroglobulinemia and marginal zone lymphoma: are they distinct or the same entity? Berger F; Traverse-Glehen A; Felman P; Callet-Bauchu E; Baseggio L; Gazzo S; Thieblemont C; Ffrench M; Magaud JP; Salles G; Coiffer B Clin Lymphoma; 2005 Mar; 5(4):220-4. PubMed ID: 15794852 [TBL] [Abstract][Full Text] [Related]
10. Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease. Cao XX; Meng Q; Cai H; He TH; Zhang CL; Su W; Sun J; Li Y; Xu W; Zhou DB; Li J Ann Hematol; 2017 Jun; 96(6):971-976. PubMed ID: 28280994 [TBL] [Abstract][Full Text] [Related]
11. Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms. Varettoni M; Arcaini L; Zibellini S; Boveri E; Rattotti S; Riboni R; Corso A; Orlandi E; Bonfichi M; Gotti M; Pascutto C; Mangiacavalli S; Croci G; Fiaccadori V; Morello L; Guerrera ML; Paulli M; Cazzola M Blood; 2013 Mar; 121(13):2522-8. PubMed ID: 23355535 [TBL] [Abstract][Full Text] [Related]
12. IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas. Gachard N; Parrens M; Soubeyran I; Petit B; Marfak A; Rizzo D; Devesa M; Delage-Corre M; Coste V; Laforêt MP; de Mascarel A; Merlio JP; Bouabdhalla K; Milpied N; Soubeyran P; Schmitt A; Bordessoule D; Cogné M; Feuillard J Leukemia; 2013 Jan; 27(1):183-9. PubMed ID: 22944768 [TBL] [Abstract][Full Text] [Related]
13. Myeloid nuclear differentiation antigen: an aid in differentiating lymphoplasmacytic lymphoma and splenic marginal zone lymphoma in bone marrow biopsies at presentation. Righi S; Novero D; Godio L; Bertuzzi C; Bacci F; Agostinelli C; Sagramoso C; Rossi M; Piccioli M; Gazzola A; Mannu C; Roncador G; Sabattini E Hum Pathol; 2022 Jun; 124():67-75. PubMed ID: 35339566 [TBL] [Abstract][Full Text] [Related]
14. Distinctive clinical and histological features of Waldenström's macroglobulinemia and splenic marginal zone lymphoma. Arcaini L; Varettoni M; Boveri E; Orlandi E; Rattotti S; Zibellini S; Merli M; Lucioni M; Rizzi S; Gotti M; Morello L; Pascutto C; Paulli M Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):103-5. PubMed ID: 21454204 [TBL] [Abstract][Full Text] [Related]
15. MALT lymphoma with IgM paraprotein and bone marrow involvement mimicking Waldenström macroglobulinaemia. Wang SC; Huang WT; Ma MC; Medeiros LJ; Chang KC Pathology; 2019 Aug; 51(5):549-553. PubMed ID: 31202483 [No Abstract] [Full Text] [Related]
16. L265P mutation of the MYD88 gene is frequent in Waldenström's macroglobulinemia and its absence in myeloma. Mori N; Ohwashi M; Yoshinaga K; Mitsuhashi K; Tanaka N; Teramura M; Okada M; Shiseki M; Tanaka J; Motoji T PLoS One; 2013; 8(11):e80088. PubMed ID: 24224040 [TBL] [Abstract][Full Text] [Related]
17. [Nodal lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia: a clinicopathological and prognostical study]. Zhang DD; Hu PZ; Li P; Jiang GZ; Yin YH; Wang GN; Zhao WG; Zhang YP; Li WC Zhonghua Bing Li Xue Za Zhi; 2021 Jun; 50(6):592-597. PubMed ID: 34078045 [No Abstract] [Full Text] [Related]
18. Lymphoplasmacytic Lymphoma and Marginal Zone Lymphoma. Juárez-Salcedo LM; Castillo JJ Hematol Oncol Clin North Am; 2019 Aug; 33(4):639-656. PubMed ID: 31229160 [TBL] [Abstract][Full Text] [Related]